DexCom, Inc.DXCMNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+7.4%
5Y CAGR+10.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+7.4%/yr
vs +3.8%/yr prior
5Y CAGR
+10.7%/yr
Recent deceleration
Acceleration
+3.6pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $599.10M | +8.5% |
| 2024 | $552.40M | +9.2% |
| 2023 | $505.80M | +4.5% |
| 2022 | $484.20M | -19.9% |
| 2021 | $604.20M | +67.9% |
| 2020 | $359.90M | +31.6% |
| 2019 | $273.50M | -34.5% |
| 2018 | $417.40M | +125.1% |
| 2017 | $185.40M | +18.8% |
| 2016 | $156.10M | - |